Shaping a healthier, brighter future
We aim to be your reliable and trusted partner, delivering excellence, embracing accountability and transparency in every interaction with a tenacious spirit that drives continuous improvement.
We develop and manufacture non-exclusive APIs – both Prime APIs – comprising large volume, mature molecules, and Specialty APIs – comprising lower volume, complex molecules with less competition.
We provide an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Our services include development and manufacturing of peptides from milligrams to multi-kilogram scale by standard sequential chemical peptide syntheses and segment condensation strategies.
About Neuland
Neuland is a leading global API Contract Development and Manufacturing Organization (CDMO). We support biotechnology and pharmaceutical companies in the design, development and manufacturing of complex active pharmaceutical ingredients (APIs).
We develop small molecules and peptides for clinical trials and beyond, with the capacity to scale-up through every stage of the product lifecycle to commercial manufacturing.
Neuland works to understand our manufacturing process and develops process improvements. The team carefully considers alternatives and implement optimizations.
Sustainability
At Neuland, we are actively integrating sustainability and Environmental, Social and Governance (ESG) priorities across our operations. Our sustainability goals have been derived through effective communication with our stakeholders’ end encompass six key themes: environmental stewardship, sustainable supply chain, employee nurturing, upholding human rights and ethics, customer-centricity, and economic value creation.
